Stunting and wasting in neurological Wilson disease: Role of copper, zinc, and insulin‐like growth factor‐I

Abstract

ObjectivesCopper (Cu) and zinc (Zn) are important trace elements for the growth and development of children. In Wilson disease (WD), impaired Cu metabolism may affect growth. This study was conducted to evaluate the height and weight of children with neurological WD and correlate these with serum Cu, Zn, and insulin‐like growth factor‐I (IGF‐I).MethodsThis prospective cohort study was conducted in a tertiary care teaching institute. Children with neurologic WD were included. The height, weight, and body‐mass index of each child were measured and categorized according to the revised national growth chart. Serum Cu, Zn, calcium, alkaline phosphatase, albumin, thyroid‐stimulating hormone, and urinary‐Cu were measured. Serum IGF‐1 was measured by enzyme‐linked immunosorbent assay. The relationship between height and weight with trace elements and IGF was analyzed using parametric or non‐parametric tests.ResultsThere were 52 children (5–18 years) with neurologic WD. Thirty‐six (69.2%) children had normal height, 12 (23.1%) were tall, and 4 (7.7%) were stunted. Forty‐six (88.5%) children had normal weight and six (11.5%) children were underweight. IGF‐1 correlated with height, weight, duration of treatment, and serum Zn level. About 15.4% of children had stunting and/or wasting, which was associated with low levels of serum IGF‐I, Zn, and calcium.ConclusionsStunting and/or wasting occurs in 15.4% of children with neurologic WD and is associated with reduced serum IGF‐I, Zn, and calcium concentration. Adjunctive Zn and calcium treatment may help in achieving normal growth.